Log in to your Inderes Free account to see all free content on this page.
Simris Group
0.09 SEK
+11.97 %
Less than 1K followers
SIMRIS B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+11.97 %
-9.29 %
+47.21 %
+109.81 %
-5.47 %
+0.90 %
-71.68 %
-84.34 %
-98.39 %
Simris Group is a biotechnology company. The company is focused on research and development of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. Simris Group was founded in 2011 and is headquartered in Hammenhög.
Read moreMarket cap
121.21M SEK
Turnover
10.47K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
13.5.
2026
Interim report Q1'26
27.5.
2026
General meeting '26
12.8.
2026
Interim report Q2'26
All
Press releases
3rd party
ShowingAll content types
Simris evaluating options to expand its ADC-payload development programme and prepare for the next funding round to accelerate its plans.
Simis provides an update on the divestment of its assets in Hammenhög, Sweden
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio